Anti-inflammatory activity of ivermectin in late-stage COVID-19 may reflect activation of systemic glycine receptors
Dr James J Dinicolantonio, Jorge Barroso-Aranda, Mark F Mccarty
Open Heart, doi:10.1136/openhrt-2021-001655
somewhat analogous anti-inflammatory protection in COVID-19, as has previously been suggested. 26 27 However, in light of accumulating evidence that ivermectin may have important utility for the primary prevention of COVID-19, it is likely that it also exerts an antiviral effect with respect to SARS-CoV-2, as suggested by in vitro studies. 3 28 It is not clear whether glycine receptor agonism might have anything to do with this effect.
References
Baudou, Lespine, Durrieu, Serious Ivermectin Toxicity and Human ABCB1 Nonsense Mutations, N Engl J Med,
doi:10.1056/NEJMc1917344Didier, Loor, Decreased biotolerability for ivermectin and cyclosporin A in mice exposed to potent P-glycoprotein inhibitors, Int J Cancer,
doi:10.1002/ijc.2910630220Ding, Svingen, Pedersen, Plasma glycine and risk of acute myocardial infarction in patients with suspected stable angina pectoris, J Am Heart Assoc,
doi:10.1161/JAHA.115.002621Dinicolantonio, Barroso, Mccarty, Ivermectin may be a clinically useful anti-inflammatory agent for late-stage COVID-19, Open Heart,
doi:10.1136/openhrt-2020-001350Dinicolantonio, Mccarty, Thrombotic complications of COVID-19 may reflect an upregulation of endothelial tissue factor expression that is contingent on activation of endosomal NADPH oxidase, Open Heart,
doi:10.1136/openhrt-2020-001337Froh, Thurman, Wheeler, Molecular evidence for a glycine-gated chloride channel in macrophages and leukocytes, Am J Physiol Gastrointest Liver Physiol,
doi:10.1152/ajpgi.00503.2001Li, Bradford, Wheeler, Dietary glycine prevents peptidoglycan polysaccharide-induced reactive arthritis in the rat: role for glycine-gated chloride channel, Infect Immun,
doi:10.1128/IAI.69.9.5883-5891.2001Lynagh, Webb, Dixon, Molecular determinants of ivermectin sensitivity at the glycine receptor chloride channel, J Biol Chem,
doi:10.1074/jbc.M111.262634Mccarty, Iloki-Assanga, Lujan, Activated glycine receptors may decrease endosomal NADPH oxidase activity by opposing ClC-3-mediated efflux of chloride from endosomes, Med Hypotheses,
doi:10.1016/j.mehy.2019.01.012Rodrigues, De Sá, Ishimoto, Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients, J Exp Med,
doi:10.1084/jem.20201707Schmith, Zhou, Lohmer, The Approved dose of ivermectin alone is not the ideal dose for the treatment of COVID-19, Clin Pharmacol Ther,
doi:10.1002/cpt.1889Shan, Haddrill, Lynch, Ivermectin, Ivermectin, an unconventional agonist of the glycine receptor chloride channel, J Biol Chem,
doi:10.1074/jbc.M011264200Viktorov, Ivermectin inhibits activation of Kupffer cells induced by lipopolysaccharide toxin
Wang, Lynch, A comparison of glycine-and ivermectinmediated conformational changes in the glycine receptor ligandbinding domain, Int J Biochem Cell Biol,
doi:10.1016/j.biocel.2011.11.005Wheeler, Rose, Yamashima, Dietary glycine blunts lung inflammatory cell influx following acute endotoxin, Am J Physiol Lung Cell Mol Physiol,
doi:10.1152/ajplung.2000.279.2.L390Wheeler, Stachlewitz, Yamashina, Glycine-gated chloride channels in neutrophils attenuate calcium influx and superoxide production, Faseb J,
doi:10.1096/fasebj.14.3.476Zhang, Ma, Jiang, Glycine attenuates lipopolysaccharideinduced acute lung injury by regulating NLRP3 inflammasome and NRF2 signaling, Nutrients,
doi:10.3390/nu12030611Zhang, Song, Ci, Ivermectin inhibits LPS-induced production of inflammatory cytokines and improves LPS-induced survival in mice, Inflamm Res,
doi:10.1007/s00011-008-8007-8{ 'indexed': {'date-parts': [[2023, 4, 11]], 'date-time': '2023-04-11T08:08:39Z', 'timestamp': 1681200519757},
'reference-count': 28,
'publisher': 'BMJ',
'issue': '1',
'license': [ { 'start': { 'date-parts': [[2021, 4, 19]],
'date-time': '2021-04-19T00:00:00Z',
'timestamp': 1618790400000},
'content-version': 'unspecified',
'delay-in-days': 18,
'URL': 'http://creativecommons.org/licenses/by-nc/4.0/'}],
'content-domain': {'domain': ['bmj.com'], 'crossmark-restriction': True},
'published-print': {'date-parts': [[2021, 4]]},
'DOI': '10.1136/openhrt-2021-001655',
'type': 'journal-article',
'created': {'date-parts': [[2021, 4, 19]], 'date-time': '2021-04-19T16:39:13Z', 'timestamp': 1618850353000},
'page': 'e001655',
'update-policy': 'http://dx.doi.org/10.1136/crossmarkpolicy',
'source': 'Crossref',
'is-referenced-by-count': 6,
'title': 'Anti-inflammatory activity of ivermectin in late-stage COVID-19 may reflect activation of '
'systemic glycine receptors',
'prefix': '10.1136',
'volume': '8',
'author': [ { 'ORCID': 'http://orcid.org/0000-0002-7888-1528',
'authenticated-orcid': False,
'given': 'James J',
'family': 'DiNicolantonio',
'sequence': 'first',
'affiliation': []},
{'given': 'Jorge', 'family': 'Barroso-Aranda', 'sequence': 'additional', 'affiliation': []},
{'given': 'Mark F', 'family': 'McCarty', 'sequence': 'additional', 'affiliation': []}],
'member': '239',
'published-online': {'date-parts': [[2021, 4, 19]]},
'reference': [ { 'key': '2021041909351020000_8.1.e001655.1',
'doi-asserted-by': 'publisher',
'DOI': '10.1007/s00011-008-8007-8'},
{ 'key': '2021041909351020000_8.1.e001655.2',
'doi-asserted-by': 'publisher',
'DOI': '10.1136/openhrt-2020-001350'},
{ 'key': '2021041909351020000_8.1.e001655.3',
'unstructured': 'Covid Analysis . Ivermectin is effective for COVID-19: real-time meta '
'analysis of 44 studies, 2021.'},
{ 'key': '2021041909351020000_8.1.e001655.4',
'doi-asserted-by': 'publisher',
'DOI': '10.1074/jbc.M011264200'},
{ 'key': '2021041909351020000_8.1.e001655.5',
'doi-asserted-by': 'publisher',
'DOI': '10.1074/jbc.M111.262634'},
{ 'key': '2021041909351020000_8.1.e001655.6',
'doi-asserted-by': 'crossref',
'first-page': '335',
'DOI': '10.1016/j.biocel.2011.11.005',
'article-title': 'A comparison of glycine- and ivermectin-mediated conformational changes '
'in the glycine receptor ligand-binding domain',
'volume': '44',
'author': 'Wang',
'year': '2012',
'journal-title': 'Int J Biochem Cell Biol'},
{ 'key': '2021041909351020000_8.1.e001655.7',
'doi-asserted-by': 'publisher',
'DOI': '10.1007/s000180050030'},
{ 'key': '2021041909351020000_8.1.e001655.8',
'first-page': 'G1581',
'article-title': 'Kupffer cells contain a glycine-gated chloride channel',
'volume': '272',
'author': 'Ikejima',
'year': '1997',
'journal-title': 'Am J Physiol'},
{ 'key': '2021041909351020000_8.1.e001655.9',
'doi-asserted-by': 'publisher',
'DOI': '10.1128/IAI.69.9.5883-5891.2001'},
{ 'key': '2021041909351020000_8.1.e001655.10',
'doi-asserted-by': 'publisher',
'DOI': '10.1152/ajpgi.00503.2001'},
{ 'key': '2021041909351020000_8.1.e001655.11',
'doi-asserted-by': 'crossref',
'first-page': 'L390',
'DOI': '10.1152/ajplung.2000.279.2.L390',
'article-title': 'Dietary glycine blunts lung inflammatory cell influx following acute '
'endotoxin',
'volume': '279',
'author': 'Wheeler',
'year': '2000',
'journal-title': 'Am J Physiol Lung Cell Mol Physiol'},
{ 'key': '2021041909351020000_8.1.e001655.12',
'doi-asserted-by': 'crossref',
'first-page': '476',
'DOI': '10.1096/fasebj.14.3.476',
'article-title': 'Glycine-gated chloride channels in neutrophils attenuate calcium influx '
'and superoxide production',
'volume': '14',
'author': 'Wheeler',
'year': '2000',
'journal-title': 'Faseb J'},
{ 'key': '2021041909351020000_8.1.e001655.13',
'first-page': 'L952',
'article-title': 'Production of superoxide and TNF-alpha from alveolar macrophages is '
'blunted by glycine',
'volume': '277',
'author': 'Wheeler',
'year': '1999',
'journal-title': 'Am J Physiol'},
{ 'key': '2021041909351020000_8.1.e001655.14',
'doi-asserted-by': 'publisher',
'DOI': '10.1207/S15327914NC402_17'},
{ 'key': '2021041909351020000_8.1.e001655.15',
'doi-asserted-by': 'crossref',
'first-page': '125',
'DOI': '10.1016/j.mehy.2019.01.012',
'article-title': 'Activated glycine receptors may decrease endosomal NADPH oxidase '
'activity by opposing ClC-3-mediated efflux of chloride from endosomes',
'volume': '123',
'author': 'McCarty',
'year': '2019',
'journal-title': 'Med Hypotheses'},
{ 'key': '2021041909351020000_8.1.e001655.16',
'first-page': 'G97',
'article-title': 'A diet containing glycine improves survival in endotoxin shock in the '
'rat',
'volume': '271',
'author': 'Ikejima',
'year': '1996',
'journal-title': 'Am J Physiol'},
{ 'key': '2021041909351020000_8.1.e001655.17',
'doi-asserted-by': 'crossref',
'DOI': '10.1084/jem.20201707',
'article-title': 'Inflammasomes are activated in response to SARS-CoV-2 infection and are '
'associated with COVID-19 severity in patients',
'volume': '218',
'author': 'Rodrigues',
'year': '2021',
'journal-title': 'J Exp Med'},
{ 'key': '2021041909351020000_8.1.e001655.18',
'article-title': 'Glycine attenuates lipopolysaccharide-induced acute lung injury by '
'regulating NLRP3 inflammasome and NRF2 signaling',
'volume': '12',
'author': 'Zhang',
'year': '2020',
'journal-title': 'Nutrients'},
{ 'key': '2021041909351020000_8.1.e001655.19',
'first-page': '3',
'article-title': '[Ivermectin inhibits activation of Kupffer cells induced by '
'lipopolysaccharide toxin]',
'volume': '48',
'author': 'Viktorov',
'year': '2003',
'journal-title': 'Antibiot Khimioter'},
{ 'key': '2021041909351020000_8.1.e001655.20',
'doi-asserted-by': 'crossref',
'first-page': '762',
'DOI': '10.1002/cpt.1889',
'article-title': 'The Approved dose of ivermectin alone is not the ideal dose for the '
'treatment of COVID-19',
'volume': '108',
'author': 'Schmith',
'year': '2020',
'journal-title': 'Clin Pharmacol Ther'},
{ 'key': '2021041909351020000_8.1.e001655.21',
'doi-asserted-by': 'publisher',
'DOI': '10.1152/physrev.00042.2003'},
{ 'key': '2021041909351020000_8.1.e001655.22',
'article-title': 'Plasma glycine and risk of acute myocardial infarction in patients with '
'suspected stable angina pectoris',
'volume': '5',
'author': 'Ding',
'year': '2015',
'journal-title': 'J Am Heart Assoc'},
{ 'key': '2021041909351020000_8.1.e001655.23',
'doi-asserted-by': 'crossref',
'first-page': '263',
'DOI': '10.1002/ijc.2910630220',
'article-title': 'Decreased biotolerability for ivermectin and cyclosporin A in mice '
'exposed to potent P-glycoprotein inhibitors',
'volume': '63',
'author': 'Didier',
'year': '1995',
'journal-title': 'Int J Cancer'},
{ 'key': '2021041909351020000_8.1.e001655.24',
'doi-asserted-by': 'publisher',
'DOI': '10.1097/00008571-200111000-00012'},
{ 'key': '2021041909351020000_8.1.e001655.25',
'doi-asserted-by': 'crossref',
'first-page': '787',
'DOI': '10.1056/NEJMc1917344',
'article-title': 'Serious Ivermectin Toxicity and Human ABCB1 Nonsense Mutations',
'volume': '383',
'author': 'Baudou',
'year': '2020',
'journal-title': 'N Engl J Med'},
{ 'key': '2021041909351020000_8.1.e001655.26',
'doi-asserted-by': 'publisher',
'DOI': '10.1136/openhrt-2020-001337'},
{ 'key': '2021041909351020000_8.1.e001655.27',
'doi-asserted-by': 'crossref',
'first-page': '199',
'DOI': '10.1667/RADE-20-00146.1',
'article-title': 'Can glycine mitigate COVID-19 associated tissue damage and cytokine '
'storm?',
'volume': '194',
'author': 'Li',
'year': '2020',
'journal-title': 'Radiat Res'},
{ 'key': '2021041909351020000_8.1.e001655.28',
'doi-asserted-by': 'crossref',
'DOI': '10.1016/j.antiviral.2020.104787',
'article-title': 'The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 '
'in vitro',
'volume': '178',
'author': 'Caly',
'year': '2020',
'journal-title': 'Antiviral Res'}],
'container-title': 'Open Heart',
'original-title': [],
'language': 'en',
'link': [ { 'URL': 'https://syndication.highwire.org/content/doi/10.1136/openhrt-2021-001655',
'content-type': 'unspecified',
'content-version': 'vor',
'intended-application': 'similarity-checking'}],
'deposited': { 'date-parts': [[2021, 4, 19]],
'date-time': '2021-04-19T16:39:54Z',
'timestamp': 1618850394000},
'score': 1,
'resource': {'primary': {'URL': 'https://openheart.bmj.com/lookup/doi/10.1136/openhrt-2021-001655'}},
'subtitle': [],
'short-title': [],
'issued': {'date-parts': [[2021, 4]]},
'references-count': 28,
'journal-issue': { 'issue': '1',
'published-online': {'date-parts': [[2021, 4, 19]]},
'published-print': {'date-parts': [[2021, 4]]}},
'alternative-id': ['10.1136/openhrt-2021-001655'],
'URL': 'http://dx.doi.org/10.1136/openhrt-2021-001655',
'relation': {},
'ISSN': ['2053-3624'],
'subject': ['Cardiology and Cardiovascular Medicine'],
'container-title-short': 'Open Heart',
'published': {'date-parts': [[2021, 4]]}}
